Browsing by Author "Jović, Jasna (6603347846)"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Autoimmune pancreatitis type 1 and type 2: A report on two cases; [Autoimunski pankreatitis tipa 1 i 2](2017) ;Brčerević, Irina (57194005534) ;Doder, Radoje (18433428100) ;Perišić, Nenad (6506926303) ;Petrović, Stanko (56819184700) ;Jović, Jasna (6603347846) ;Hristović, Dejan (7801380935) ;Djordjević, Zoran (56387098100)Radić, Olga Tasić (6505906330)Introduction. Autoimmune pancreatitis is a disease associated with autoimmune mechanisms, clinically manifested mostly as obstructive icterus with or with no entire or partial enlargementof the pancreas, histological lymphoplas-mocytic infiltration, fibrosis or granulocytic epithelial lesions with a favourable therapeutic response to the application of corticosteroids. Type 1 autoimmune pancreatitis is a systemic disease befalling the group of IgG4-related diseases in contrast to type 2 which is specific for pancreas disease. Case report. We presented two cases. The first one was a 64-year-old male patient with autoimmune pancreatitis complaining of abdominal pain, weight loss, weakness and exhaustion. Clinical examination showed a rare IgG4 autoimmune pancreatitis. The second one was a 37-year-old male patient complaining of abdominal pain with diarrhea. The diagnosis made revealed the presence of type 2 autoimmune pancreatitis. Following the diagnosis, immunosuppressive therapy was administered to both patients leading to the improvement of their general condition. Conclusion. Autoimmune pancreatitis is a rare disease, sometimes not easy to differ from pancreatic tumor or bile duct tumor with poor prognosis. Thus, early recognition of the disease is very important, since adequate treatment significantly increases the course and the outcomes of the disease. © 2017, Institut za Vojnomedicinske Naucne Informacije/Documentaciju. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Creatinine-modified Child-Turcotte-Pugh score is a good predictor of a short-term survival in patients with bleeding from esophageal varices; [Child-Turcotte-Pugh skor modifikovan u odnosu na nivo kreatinina dobar je prediktor preživljavanja bolesnika sa krvarenjem iz varikoziteta jednjaka](2017) ;Radisavljević, Mirjana (55190828000) ;Bjelaković, Goran (34567603700) ;Jović, Jasna (6603347846) ;Radovanović Dinić, Biljana (26640745800) ;Benedeto Stojanov, Danijela (23471629100) ;Brzački, Vesna (35795044500)Marković Živković, Bojana (56461310200)Background/Aim. Bleeding from esophageal varices is a significant factor in mortality of patients with terminal liver cirrhosis. This complication is a major health problem for recipients on the list for liver transplant. In that regard, studying predictors of variceal bleeding episode is very importatnt. Also, it is important to find the best survival predictor among prognostic scores. The aim of the study was to compare validity of prognostic scores in assessment of survival in hospital-treated patients after bleeding from esophageal varices, and to compare validity of baseline Child Turcotte Pugh (CTP) and Modul for End-stage Liver Disease (MELD) scores with CTP creatinine modified (CTPcrea) I and II scores in assessment of survival in patients within a long-term follow-up period after the episode of bleeding from esophageal varices. Methods. The study included a total of 126 patients suffering from terminal liver cirrhosis submited to testing CTP score score I and II, MELD score, MELD Na score, integrated MELD score, MELD sodium (MESO) index, United Kingdom Model for End-Stage Liver Disease (UKELD) score and updated MELD score. Results. Patients with bleeding from esophageal varices most often had CTP score rank C (46,9%). CTP score rank B had 37.5% patients, while the smallest percentage of patients had CTP rank A, 15.6% of them. Patients who have values of CTP score higher than 10.50 and bleeding from esophagus, have 3.2 times higher chance for death outcome compared to other patients. Patients who have values of CTPcrea I score higher than 10.50 and bleeding from esophagus, have 3.1 times higher chance for death out-come than other patients. Patients who have values of CTP-crea II score higher than 11.50 and bleeding from esophagus, have 3,7 times higher chance for death outcome compared to other patients. Conclusion. Survival of patients with bleeding from esophageal varices in the short-term follow up can be predicted by following CTP score and creatinine modified CTP scores. Patients with bleeding from esophageal varices who have CTP score and CTP-crea I score higher than 10.5 and CTP-crea II score higher than 11.5, have statistically significantly higher risk from mortality within one-month follow-up compared to patients with bleeding from esophageal varices who have lower numerical values of scores of the CTP group © 2017, Institut za Vojnomedicinske Naucne Informacije/Documentaciju. All rights reserved.
